|
Post by careful2invest on Jan 12, 2018 22:23:14 GMT -5
While walking out of my Doctors office today, I saw a professional looking gentleman walk out of the Endocronologists office across the hall. I saw him again in the lobby downstairs and had to ask, I said, "are you an Endo or a patient?" He replied, neither, I am a pharmaceutical rep. I asked if he knew about Afrezza, He had, so I asked if sales are increasing from his perspective. Unfortunately, he said no.
In his opinion, the spirometry test was the biggest impediment, explaining how the Doctors schedules are always full and they just dont want to add anything more to it. I replied with how simple the test is, how they can charge for it, etc, and he said that he realized that, and went on to say that it was not just the time constraints, unfortunately, the doctors are also reluctant to change.
I realize that this is not groundbreaking news to any of us, and I am sharing this encounter because I am wondering if MNKD is able to, or if they already are working with the FDA to get that test eliminated. Or if that is even possible?
I realize that insurance coverage is improving, ads have begun, and progress is being made, albeit slowly, but the spirometry testing may be hurting sales more than calculated. We spoke for awhile and he commented on how passionate and knowledgable I was about AFREZZA. He jokingly said that I should get a job with MNKD promoting it. I guess 8 years of owning stock in MNKD, having almost $300,000.00 invested, to say that MNKD has my focus would be an understatement! I sure hope we get to fruition! And clearly, I am not alone!
Sorry such a long post, just trying to be thorough. GLTA!
|
|
|
Post by brotherm1 on Jan 12, 2018 22:35:54 GMT -5
What company is he employed by?
|
|
|
Post by mnkdfann on Jan 12, 2018 22:37:24 GMT -5
Yeah, that was my question. Maybe he was from Sanofi, and just yanking your chain. Sadly, I suspect he was likely being honest and legit.
|
|
|
Post by mango on Jan 12, 2018 22:43:48 GMT -5
The bedside spirometry test would be done by the nurse not the doctor and would take less than 5 minutes to complete. It is rather routinely performed at family med clinics nationwide. It is not a burden on the patient nor on the staff's time.
Laziness.
|
|
|
Post by careful2invest on Jan 12, 2018 22:54:33 GMT -5
The bedside spirometry test would be done by the nurse not the doctor and would take less than 5 minutes to complete. It is rather routinely performed at family med clinics nationwide. It is not a burden on the patient nor on the staff's time. Laziness. Mango, You and I , along with most on this mb realize how simple the test actually is, I am just letting you all know what was said. In addition, we have heard his point from others. And yes, Laziness is the problem, and in most of the docs eyes (that are unopen to new technology) they seem to go with and stick to "what already works" Although, unbeknownst to them, Afrezza is far superior. As far as who he worked for, I was already at my car door when I thought to ask. He did say that he was with a company that supplies/sells, (not verbatim) Afrezza, but I neglected to get the name of which one.
|
|
|
Post by olebob1 on Jan 12, 2018 22:58:21 GMT -5
While walking out of my Doctors office today, I saw a professional looking gentleman walk out of the Endocronologists office across the hall. I saw him again in the lobby downstairs and had to ask, I said, "are you an Endo or a patient?" He replied, neither, I am a pharmaceutical rep. I asked if he knew about Afrezza, He had, so I asked if sales are increasing from his perspective. Unfortunately, he said no. In his opinion, the spirometry test was the biggest impediment, explaining how the Doctors schedules are always full and they just dont want to add anything more to it. I replied with how simple the test is, how they can charge for it, etc, and he said that he realized that, and went on to say that it was not just the time constraints, unfortunately, the doctors are also reluctant to change. I realize that this is not groundbreaking news to any of us, and I am sharing this encounter because I am wondering if MNKD is able to, or if they already are working with the FDA to get that test eliminated. Or if that is even possible? I realize that insurance coverage is improving, ads have begun, and progress is being made, albeit slowly, but the spirometry testing may be hurting sales more than calculated. We spoke for awhile and he commented on how passionate and knowledgable I was about AFREZZA. He jokingly said that I should get a job with MNKD promoting it. I guess 8 years of owning stock in MNKD, having almost $300,000.00 invested, to say that MNKD has my focus would be an understatement! I sure hope we get to fruition! And clearly, I am not alone! Sorry such a long post, just trying to be thorough. GLTA! I'm in deeper than u so do not feel like the Lone Ranger. Great job promoting, u may rise to Rooks level some day!
|
|
|
Post by careful2invest on Jan 12, 2018 23:05:03 GMT -5
While walking out of my Doctors office today, I saw a professional looking gentleman walk out of the Endocronologists office across the hall. I saw him again in the lobby downstairs and had to ask, I said, "are you an Endo or a patient?" He replied, neither, I am a pharmaceutical rep. I asked if he knew about Afrezza, He had, so I asked if sales are increasing from his perspective. Unfortunately, he said no. In his opinion, the spirometry test was the biggest impediment, explaining how the Doctors schedules are always full and they just dont want to add anything more to it. I replied with how simple the test is, how they can charge for it, etc, and he said that he realized that, and went on to say that it was not just the time constraints, unfortunately, the doctors are also reluctant to change. I realize that this is not groundbreaking news to any of us, and I am sharing this encounter because I am wondering if MNKD is able to, or if they already are working with the FDA to get that test eliminated. Or if that is even possible? I realize that insurance coverage is improving, ads have begun, and progress is being made, albeit slowly, but the spirometry testing may be hurting sales more than calculated. We spoke for awhile and he commented on how passionate and knowledgable I was about AFREZZA. He jokingly said that I should get a job with MNKD promoting it. I guess 8 years of owning stock in MNKD, having almost $300,000.00 invested, to say that MNKD has my focus would be an understatement! I sure hope we get to fruition! And clearly, I am not alone! Sorry such a long post, just trying to be thorough. GLTA! I'm in deeper than u so do not feel like the Lone Ranger. Great job promoting, u may rise to Rooks level some day! Bob, I appreciate the compliment, and I'm sorry that you are down by that much $$. I realize that I am not alone with how far I am in the red on this one, but it still has left a mark! A mark that I still hold hope, will soon become just a memory. As far as making it to Sports level, That will never happen! She is on a level of her own! And that is not to minimize the value of so many that post on this mb, merely a compliment to Sports! I appreciate the time and the invaluable information shared by all of you... Well...Most of you... (Just kidding on that last part) I couldn't resist! GLTA!
|
|
|
Post by brotherm1 on Jan 12, 2018 23:20:02 GMT -5
The bedside spirometry test would be done by the nurse not the doctor and would take less than 5 minutes to complete. It is rather routinely performed at family med clinics nationwide. It is not a burden on the patient nor on the staff's time. Laziness. Mango, You and I , along with most on this mb realize how simple the test actually is, I am just letting you all know what was said. In addition, we have heard his point from others. And yes, Laziness is the problem, and in most of the docs eyes (that are unopen to new technology) they seem to go with and stick to "what already works" Although, unbeknownst to them, Afrezza is far superior. As far as who he worked for, I was already at my car door when I thought to ask. He did say that he was with a company that supplies/sells, (not verbatim) Afrezza, but I neglected to get the name of which one. What city or part of the country was this? Is it an area MNkD has reps or is advertising in?
|
|
|
Post by mango on Jan 12, 2018 23:26:32 GMT -5
Mango, You and I , along with most on this mb realize how simple the test actually is, I am just letting you all know what was said. In addition, we have heard his point from others. And yes, Laziness is the problem, and in most of the docs eyes (that are unopen to new technology) they seem to go with and stick to "what already works" Although, unbeknownst to them, Afrezza is far superior. As far as who he worked for, I was already at my car door when I thought to ask. He did say that he was with a company that supplies/sells, (not verbatim) Afrezza, but I neglected to get the name of which one. What city or part of the country was this? Is it an area MNkD has reps or is advertising in? Is that the MannKind Spaceship in your avatar?
|
|
|
Post by careful2invest on Jan 12, 2018 23:26:39 GMT -5
Mango, You and I , along with most on this mb realize how simple the test actually is, I am just letting you all know what was said. In addition, we have heard his point from others. And yes, Laziness is the problem, and in most of the docs eyes (that are unopen to new technology) they seem to go with and stick to "what already works" Although, unbeknownst to them, Afrezza is far superior. As far as who he worked for, I was already at my car door when I thought to ask. He did say that he was with a company that supplies/sells, (not verbatim) Afrezza, but I neglected to get the name of which one. What city or part of the country was this? Is it an area MNkD has reps or is advertising in? I'm in Ohio. And yes, the Afrezza commercials are seen on our major networks quite often, even during primetime. And I recently created a thread noting that Dexcom is now being advertised on tv in my area promoting that their CGM is now covered by Medicare. Hopefully, we start seeing an increase in sales very soon! I still hold hope for a large BP to partner with us to promote in the USA and take Afrezza to international markets. Mike recently tweeted that he will be making an announcement "before March". One can only hope! GLTA!
|
|
|
Post by brotherm1 on Jan 12, 2018 23:41:26 GMT -5
Well if he is a phamaceutical rep he would not say Afrezza sales are not increasing if he works for MNkD. And since he came out of the endo office I would say there’s a very good chance he works for a competitor.
PS. glad to hear you are seeing a lot of TV ads out there. Thanks
|
|
|
Post by careful2invest on Jan 12, 2018 23:50:26 GMT -5
Well if he is a phamaceutical rep he would not say Afrezza sales are not increasing if he works for MNkD. And since he came out of the endo office I would say there’s a very good chance he works for a competitor. He definitly was not an employee of MNKD. As I knew more about Afrezza than he did. He was definitely a sales rep. For whom...IDK.
|
|
|
Post by careful2invest on Jan 13, 2018 0:05:15 GMT -5
While walking out of my Doctors office today, I saw a professional looking gentleman walk out of the Endocronologists office across the hall. I saw him again in the lobby downstairs and had to ask, I said, "are you an Endo or a patient?" He replied, neither, I am a pharmaceutical rep. I asked if he knew about Afrezza, He had, so I asked if sales are increasing from his perspective. Unfortunately, he said no. In his opinion, the spirometry test was the biggest impediment, explaining how the Doctors schedules are always full and they just dont want to add anything more to it. I replied with how simple the test is, how they can charge for it, etc, and he said that he realized that, and went on to say that it was not just the time constraints, unfortunately, the doctors are also reluctant to change. I realize that this is not groundbreaking news to any of us, and I am sharing this encounter because I am wondering if MNKD is able to, or if they are already working with the FDA to get that test eliminated. Or if that is even possible?I realize that insurance coverage is improving, ads have begun, and progress is being made, albeit slowly, but the spirometry testing may be hurting sales more than calculated. We spoke for awhile and he commented on how passionate and knowledgable I was about AFREZZA. He jokingly said that I should get a job with MNKD promoting it. I guess 8 years of owning stock in MNKD, having almost $300,000.00 invested, to say that MNKD has my focus would be an understatement! I sure hope we get to fruition! And clearly, I am not alone! Sorry such a long post, just trying to be thorough. GLTA! Well, While I've enjoyed all of your responses, The main reason for this post was more than just sharing an experience with all of you. My questions (now in bold print ) remain unanswered. Does anybody have any information about this? Thanks! GLTA
|
|
|
Post by mytakeonit on Jan 13, 2018 0:33:27 GMT -5
Great post and warrants the second thread. As far as eliminating the spirometry test ... patients should walk in with a blown up balloon and they would pass automatically. Ha!
What caught my eye was your investment level ... because I'm definitely beyond that. But why is it, that buying more shares later at 82 cents makes me feel like the hole is shallower. Ha!
The answer to the question is in my second thread ...
|
|
|
Post by mango on Jan 13, 2018 1:48:59 GMT -5
While walking out of my Doctors office today, I saw a professional looking gentleman walk out of the Endocronologists office across the hall. I saw him again in the lobby downstairs and had to ask, I said, "are you an Endo or a patient?" He replied, neither, I am a pharmaceutical rep. I asked if he knew about Afrezza, He had, so I asked if sales are increasing from his perspective. Unfortunately, he said no. In his opinion, the spirometry test was the biggest impediment, explaining how the Doctors schedules are always full and they just dont want to add anything more to it. I replied with how simple the test is, how they can charge for it, etc, and he said that he realized that, and went on to say that it was not just the time constraints, unfortunately, the doctors are also reluctant to change. I realize that this is not groundbreaking news to any of us, and I am sharing this encounter because I am wondering if MNKD is able to, or if they are already working with the FDA to get that test eliminated. Or if that is even possible?I realize that insurance coverage is improving, ads have begun, and progress is being made, albeit slowly, but the spirometry testing may be hurting sales more than calculated. We spoke for awhile and he commented on how passionate and knowledgable I was about AFREZZA. He jokingly said that I should get a job with MNKD promoting it. I guess 8 years of owning stock in MNKD, having almost $300,000.00 invested, to say that MNKD has my focus would be an understatement! I sure hope we get to fruition! And clearly, I am not alone! Sorry such a long post, just trying to be thorough. GLTA! Well, While I've enjoyed all of your responses, The main reason for this post was more than just sharing an experience with all of you. My questions (now in bold print ) remain unanswered. Does anybody have any information about this? Thanks! GLTA I don't think the spirometry requirement will be going away. Seriously, the spirometry test is so simple and quick to do—this is not a reason to prevent a physician from prescribing Afrezza...unless he or she is lazy, receiving kickbacks to prescribe another prandial insulin, or financially involved with a competitor.
|
|